KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Charles River Laboratories International (CRL) Other Gross PP&E Adjustments (2016 - 2025)

Charles River Laboratories International (CRL) has 16 years of Other Gross PP&E Adjustments data on record, last reported at $2.8 billion in Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 6.53% year-over-year to $2.8 billion; the TTM value through Dec 2025 reached $2.8 billion, down 6.53%, while the annual FY2025 figure was $2.8 billion, 6.53% down from the prior year.
  • Other Gross PP&E Adjustments reached $2.8 billion in Q4 2025 per CRL's latest filing, up from $2.7 billion in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $3.0 billion in Q4 2024 and bottomed at -$408.5 million in Q2 2023.
  • Average Other Gross PP&E Adjustments over 5 years is $1.3 billion, with a median of $2.2 billion recorded in 2021.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 63.61% in 2021, then surged 824.26% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $2.1 billion in 2021, then grew by 6.37% to $2.2 billion in 2022, then increased by 15.48% to $2.6 billion in 2023, then rose by 17.37% to $3.0 billion in 2024, then decreased by 6.53% to $2.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $2.8 billion in Q4 2025, $2.7 billion in Q3 2025, and $2.7 billion in Q2 2025.